bioRxivMicrobiology
Extensive characterization of HIV-1 reservoirs reveals links to plasma viremia before and during analytical treatment interruption
B. Cole, L. Lambrechts, Z. Boyer, Y. Noppe, M.-A. De Scheerder, J.-S. Eden, B. Vrancken, T. Schlub, L. M. Frenkel, S. McLaughlin, S. Palmer, L. Vandekerckhove
Abstract
The HIV-1 reservoir is composed of cells harboring latent proviruses that are capable of contributing to viremia upon antiretroviral treatment (ART) interruption. Although this reservoir is known to be maintained by clonal expansion, the contribution of large, infected cell clones to residual viremia and viral rebound remains underexplored. Here, we conducted an extensive analysis on four ART-treated individuals who underwent an analytical treatment interruption (ATI). We performed subgenomic (V1-V3 env), near full-length proviral and integration site sequencing, and used multiple displacement amplification to sequence both the integration site and provirus from single HIV-infected cells. We found eight proviruses that could phylogenetically be linked to plasma virus obtained before or during the ATI. This study highlights a role for HIV-infected cell clones in the maintenance of the replication-competent reservoir and suggests that infected cell clones can directly contribute to rebound viremia upon ATI.
- organism: human
- assay: bulk RNA-seq
- research focus: host-pathogen & immune response
- approach: statistical model
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- HIV-1 Viremia Not Suppressible By Antiretroviral Therapy Can Originate from Large T-Cell Clones Producing Infectious Virus
Elias Konstantine Halvas, Kevin W. Joseph, … John W. Mellors·Journal of Clinical InvestigationPeer-reviewed·Oct 4, 2020
- In-depth single-cell analysis of translation-competent HIV-1 reservoirs identifies cellular sources of plasma viremia
B. Cole, L. Lambrechts, … L. Vandekerckhove·bioRxiv·Feb 15, 2021
- A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation
D. B. Reeves, E. R. Duke, … J. T. Schiffer·bioRxiv·Sep 7, 2018
- HIV reservoirs are dominated by genetically younger and clonally enriched proviruses
Natalie N. Kinloch, Aniqa Shahid, … Zabrina L. Brumme·mBioPeer-reviewed·Nov 16, 2023
- HIV-1 Rebound Virus Consists of a Small Number of Lineages That Entered the Reservoir Close to ART Initiation
Lynn Tyers, Matthew Moeser, … Sarah Joseph·bioRxiv·Jan 29, 2025
- Persistence of intact HIV-1 proviruses in the brain during antiretroviral therapy
W. Sun, Y. Rassadkina, … M. Lichterfeld·bioRxiv·Jun 26, 2023